MMED's catalyst-free 11.3% spike retraces at least half within three weeks.

Predicted 2026-08-30 · Resolves 2026-09-20 · markets · Global

68%

ORACLE CONFIDENCE

⏳ Pending

Every outcome is scored publicly in the ledger.

Mind Medicine (a psychedelic drug company) saw its stock jump 11.3% with no real news — no new drug results, no partnership announcement, nothing. Historically, when a small, thinly-traded stock like this jumps without a good reason, it tends to drift back down within weeks. If this prediction is right, the stock gives back at least half that gain by September 20, 2026.

Resolution rule: YES if MIND Medicine (MNMD/MMED) closing price on 2026-09-20 has retraced at least 50% of the 11.3% spike gain (i.e., closes at or below the midpoint between the pre-spike close and the spike-day close), absent any MMED-issued clinical or partnership press release explaining a new fundamental catalyst. Source: Nasdaq/Yahoo Finance closing price for MNMD and MindMed IR press releases. Check date: 2026-09-20.

Catalyst-free spikes in thin psychedelic names mean-revert. No confirming clinical or partnership news accompanied this move; it's momentum/retail, not de-risking. Anchored to today's specific 11.3% MMED move.

5 new falsifiable predictions, every day at 12:05 PM ET.

Get tomorrow's Oracle →